Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-06-06 WOOD LAUREN Chief Medical Officer Grant or award · Stock Option (Right To Purchase) +62,715 62,715
2019-06-06 CONN GREGORY Chief Scientific Officer Grant or award · Stock Option (Right To Purchase) +40,000 40,000
2019-06-06 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +62,715 62,715
2019-03-15 Macdonald R. Loch Director Exercise or conversion +10,000 580,602
2019-03-15 Macdonald R. Loch Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 Spiegel Robert J. Director Exercise or conversion +10,000 48,661
2019-03-15 Spiegel Robert J. Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 Saik Andrew Chief Financial Officer Exercise or conversion +82,999 82,999
2019-03-15 Saik Andrew Chief Financial Officer Exercise or conversion · Restricted Stock Units −82,999 0
2019-03-15 Ratcliffe Liam Director Exercise or conversion +10,000 10,000
2019-03-15 Ratcliffe Liam Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Exercise or conversion +49,766 59,766
2019-03-15 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Exercise or conversion · Restricted Stock Units −49,766 0
2019-03-15 LOUGHLIN JAMES J Director Exercise or conversion +10,000 26,625
2019-03-15 LOUGHLIN JAMES J Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 Leuthner Brian A President and CEO Exercise or conversion +169,032 239,268
2019-03-15 Leuthner Brian A President and CEO Exercise or conversion · Restricted Stock Units −169,032 0
2019-03-15 BLECH ISAAC Director Exercise or conversion +10,000 10,000
2019-03-15 BLECH ISAAC Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 BLECH ISAAC Director Exercise or conversion +10,000 10,000

Page 7 of 18 · 346 trades